Fifth International Conference on Tumor Microenvironment: Progression, Therapy a

第五届国际肿瘤微环境会议：进展、治疗

• 批准号: 7804830
• 负责人: Yves A DeClerck
• 金额: $ 1.7万
• 依托单位: AMERICAN ASSOCIATION FOR CANCER RESEARCH
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-01 至 2010-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7804830
• 关键词: American Association of Cancer Research; Antibodies; Area; Arts; Awareness; Biological Response Modifiers; Bone Marrow Cells; Cells; Clinical Research; Collaborations; Communities; Development; Drug resistance; Endothelium; Extracellular Matrix; Fibroblasts; France; Gene Expression Regulation; Goals; Immunity; Industry; Inflammation; International; Investigation; Knowledge; Malignant Neoplasms; National Cancer Institute; Neoplasm Metastasis; Phase; Prevention therapy; Research; Research Personnel; Research Priority; Role; Scientist; Series; Societies; Students; Time; Translational Research; cancer cell; cancer therapy; chemokine; cytokine; improved; lectures; meetings; neoplastic cell; novel; planetary Atmosphere; posters; pre-clinical; public health relevance; symposium; therapeutic target; tumor; tumor progression

DESCRIPTION (provided by applicant): In 2002, the National Cancer Institute identified the tumor microenvironment as a priority research area and initiated efforts to expand our knowledge of the cells and factors that normally populate the microenvironment, as well as to advance our understanding of how these microenvironment components interact with tumor cells. The Fifth International Conference on Tumor Microenvironment: Progression, Therapy and Prevention, is timely as many novel concepts have emerged in the field since that time and the contribution of the microenvironment to cancer progression is increasingly recognized. This conference is jointly sponsored by the International Cancer Microenvironment Society (ICMS), the American Association for Cancer Research (AACR), and the French Institut National du Cancer (INCa), and will be held in Versailles, France from October 20-24, 2009. The meeting will be held over 3.5 days and consist of 7 plenary sessions, 8 concurrent symposia, and 1 poster session. Plenary sessions will focus on Regulation of Gene Expression in the Tumor and in Non-Tumor Cells in the Microenvironment; The Role of the Microenvironment in Metastasis and Tumor Progression; Interactions of Tumor Cells with: Bone Marrow Cells, Immunocytes, Endothelium, Fibroblasts, ECM, and Soluble Immune Mediators (Antibodies, Cytokines, and Chemokines); Inflammation and Protective Immunity in the Tumor Microenvironment (two sessions); and Therapeutic Targeting of Tumor-Microenvironment Interactions: Pre Clinical and Clinical Studies (two sessions). The organizers' goals are to present a series of state-of-the-art lectures given by nationally and internationally renowned scientists from diverse backgrounds around a unified theme: "The microenvironment and its role in cancer progression, therapy, and prevention;" increase the awareness of the scientific community, and in particular more junior investigators and students, of the importance of this field of research in cancer and to encourage them to initiate investigations in this area; accelerate translational research by bringing together scientists, clinicians, academicians, and researchers of the industry; and provide ample opportunities for open discussion, scientific interaction, and collaboration among scientists with complementary expertise by conducting such a conference in a relaxed atmosphere. To hold another conference on this topic in 2009 is appropriate considering the rapid phase of development of this field of cancer investigation.

描述(申请人提供)：2002年，国家癌症研究所将肿瘤微环境确定为优先研究领域，并开始努力扩大我们对通常存在于微环境中的细胞和因素的知识，以及促进我们对这些微环境成分如何与肿瘤细胞相互作用的理解。 第五届国际肿瘤微环境会议：进展、治疗和预防是及时的，因为自那时以来，该领域出现了许多新概念，微环境对癌症进展的贡献日益得到承认。本次会议由国际癌症微环境学会(ICMS)、美国癌症研究协会(AACR)和法国国立癌症研究所(INCA)联合主办，将于2009年10月20-24日在法国凡尔赛举行。 会议为期3.5天，由7次全体会议、8次并行座谈会和1次海报会议组成。全体会议将集中讨论微环境中肿瘤和非肿瘤细胞中基因表达的调控；微环境在转移和肿瘤进展中的作用；肿瘤细胞与：骨髓细胞、免疫细胞、内皮细胞、成纤维细胞、细胞外基质和可溶性免疫介质(抗体、细胞因子和趋化因子)的相互作用；肿瘤微环境中的炎症和保护性免疫(两会)；以及肿瘤与微环境相互作用的治疗靶向：临床前和临床研究(两会)。 主办方的目标是围绕一个统一的主题，由来自不同背景的国内外知名科学家发表一系列最先进的演讲：“微环境及其在癌症进展、治疗和预防中的作用”；提高科学界，特别是更多初级研究人员和学生对这一癌症研究领域重要性的认识，并鼓励他们发起这一领域的研究；通过将科学家、临床医生、院士和行业研究人员聚集在一起，加速翻译研究；并通过在轻松的气氛中举行这样的会议，为具有互补专业知识的科学家之间的公开讨论、科学互动和合作提供了充足的机会。 考虑到这一癌症研究领域的快速发展阶段，在2009年就这一主题举行另一次会议是合适的。